 Heart Failure
"Heart Failure" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Descriptor ID |
D006333
|
| MeSH Number(s) |
C14.280.434
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heart Failure".
Below are MeSH descriptors whose meaning is more specific than "Heart Failure".
This graph shows the total number of publications written about "Heart Failure" by people in this website by year, and whether "Heart Failure" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 6 | 3 | 9 | | 1992 | 3 | 2 | 5 | | 1993 | 8 | 1 | 9 | | 1994 | 6 | 1 | 7 | | 1995 | 4 | 2 | 6 | | 1996 | 3 | 2 | 5 | | 1997 | 9 | 3 | 12 | | 1998 | 7 | 0 | 7 | | 1999 | 6 | 1 | 7 | | 2000 | 11 | 5 | 16 | | 2001 | 14 | 6 | 20 | | 2002 | 12 | 2 | 14 | | 2003 | 22 | 3 | 25 | | 2004 | 19 | 4 | 23 | | 2005 | 27 | 8 | 35 | | 2006 | 14 | 5 | 19 | | 2007 | 27 | 4 | 31 | | 2008 | 26 | 2 | 28 | | 2009 | 30 | 3 | 33 | | 2010 | 36 | 11 | 47 | | 2011 | 38 | 7 | 45 | | 2012 | 48 | 5 | 53 | | 2013 | 59 | 7 | 66 | | 2014 | 58 | 15 | 73 | | 2015 | 54 | 9 | 63 | | 2016 | 78 | 11 | 89 | | 2017 | 80 | 8 | 88 | | 2018 | 65 | 13 | 78 | | 2019 | 80 | 12 | 92 | | 2020 | 72 | 6 | 78 | | 2021 | 44 | 4 | 48 |
To return to the timeline, click here.
Below are the most recent publications written about "Heart Failure" by people in Profiles.
-
Rosano GMC, Allen LA, Abdin A, Lindenfeld J, O'Meara E, Lam CSP, Lancellotti P, Savarese G, Gottlieb SS, Teerlink J, Wintrich J, Böhm M. Drug Layering in Heart Failure: Phenotype-Guided Initiation. JACC Heart Fail. 2021 11; 9(11):775-783.
-
Loi MM, Eissa H, Weinman JP, Abman SH, Galambos C, Carpenter TC. Case 1-2021: A 10-Year-Old Male With Respiratory Failure, Pleural Effusions, and Renal Failure 60 Days After Hematopoietic Stem Cell Transplant. Pediatr Crit Care Med. 2021 10 01; 22(10):e524-e531.
-
Ho CY, Day SM, Axelsson A, Russell MW, Zahka K, Lever HM, Pereira AC, Colan SD, Margossian R, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Bundgaard H, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Vargas JD, Soslow JH, Becker JR, Seidman CE, Lakdawala NK, Cirino AL, Burns KM, McMurray JJV, MacRae CA, Solomon SD, Orav EJ, Braunwald E. Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. Nat Med. 2021 10; 27(10):1818-1824.
-
Goyal P, Reshetnyak E, Khan S, Musse M, Navi BB, Kim J, Allen LA, Banerjee S, Elkind MSV, Shah SJ, Yancy C, Michos ED, Devereux RB, Okin PM, Weinsaft JW, Safford MM. Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19. Circ Heart Fail. 2021 09; 14(9):e008354.
-
Greene SJ, Choi S, Lippmann SJ, Mentz RJ, Greiner MA, Hardy NC, Hammill BG, Luo N, Samsky MD, Heidenreich PA, Laskey WK, Yancy CW, Peterson PN, Curtis LH, Hernandez AF, Fonarow GC, O'Brien EC. Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction. J Am Heart Assoc. 2021 08 17; 10(16):e021459.
-
Carnicelli AP, Lippmann SJ, Greene SJ, Mentz RJ, Greiner MA, Hardy NC, Hammill BG, Shen X, Yancy CW, Peterson PN, Allen LA, Fonarow GC, O'Brien EC. Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure. J Card Fail. 2021 08; 27(8):826-836.
-
DeVore AD, Granger BB, Fonarow GC, Al-Khalidi HR, Albert NM, Lewis EF, Butler J, Piña IL, Allen LA, Yancy CW, Cooper LB, Felker GM, Kaltenbach LA, McRae AT, Lanfear DE, Harrison RW, Disch M, Ariely D, Miller JM, Granger CB, Hernandez AF. Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction: The CONNECT-HF Randomized Clinical Trial. JAMA. 2021 07 27; 326(4):314-323.
-
Lerakis S, Kini AS, Asch FM, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Weissman NJ, Rinaldi MJ, Sharma SK, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Tang GHL, Li D, Crowley A, Lindenfeld J, Abraham WT, Mack MJ, Stone GW. Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunction. EuroIntervention. 2021 Jul 20; 17(4):e335-e342.
-
Eldemire R, Tharp CA, Taylor MRG, Sbaizero O, Mestroni L. The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy. Curr Cardiol Rep. 2021 07 16; 23(9):121.
-
Eikelboom JW, Bhatt DL, Fox KAA, Bosch J, Connolly SJ, Anand SS, Avezum A, Berkowitz SD, Branch KRH, Dagenais GR, Félix C, Guzik TJ, Hart RG, Maggioni AP, Muehlhofer E, Sharma M, Shestakovska O, Yusuf S. Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease. J Am Coll Cardiol. 2021 07 06; 78(1):14-23.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|